Mayer Eldon C. III 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Jan 31, 2020
Insider Transaction Report
Form 4
Mayer Eldon C. III
Director
Transactions
- Award
Common Stock
2020-01-31+7,500→ 37,500 total - Award
Stock Option ( Right to Buy)
2020-01-31+150,000→ 150,000 totalExercise: $12.36Exp: 2030-01-30→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents shares underlying Restricted Stock Units award that vest according to the following schedule: 50% shares will vest on the first anniversary of the vesting commencement date of January 6, 2020, and the remaining 50% shares will vest on the second anniversary of the vesting commencement date.
- [F2]The option vests as follows: 25% of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 6, 2020, with the remaining shares to vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date.